| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.18 | 0.007 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.009 |